by cjbest on 2/16/21, 4:57 AM with 1 comments
by nyokodo on 2/16/21, 5:39 AM
It's highly doubtful that a full round of studies will be required to approve a new form of the COVID vaccine. We don't need that for each year's Flu vaccine, neither will we need it for each year's COVID vaccine if that proves to be necessary. Production is vastly more efficient than in past months and getting better all the time, and because vaccines can be made multivalent i.e. protecting against multiple strains and changed very quickly production should not be a significant problem in the future. Distribution is already enormously more smooth than it was a month ago and with new strains there's no reason to ramp all of that down. This article appears to be ridiculously pessimistic about future vaccine logistics.